Stericycle Inc. (NASDAQ:SRCL)‘s stock had its “outperform” rating reiterated by Barrington Research in a report issued on Wednesday. They currently have a $88.00 price target on the stock, down from their previous price target of $100.00. Barrington Research’s target price points to a potential upside of 13.78% from the stock’s current price.
Other research analysts have also issued reports about the company. Jefferies Group reaffirmed a “buy” rating and issued a $112.50 target price (down from $125.00) on shares of Stericycle in a research report on Wednesday, September 7th. Zacks Investment Research raised Stericycle from a “hold” rating to a “buy” rating and set a $117.00 price objective on the stock in a report on Monday, July 11th. Wellington Shields lowered Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Finally, Macquarie initiated coverage on Stericycle in a report on Thursday, August 25th. They set a “neutral” rating and a $96.00 price objective on the stock. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $103.54.
Shares of Stericycle (NASDAQ:SRCL) traded down 0.97% during midday trading on Wednesday, hitting $76.59. The stock had a trading volume of 555,806 shares. The firm has a market cap of $6.51 billion, a PE ratio of 26.96 and a beta of 0.20. Stericycle has a 12-month low of $76.50 and a 12-month high of $151.57. The firm has a 50-day moving average of $82.36 and a 200 day moving average of $99.90.
Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, hitting the consensus estimate of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The company had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. During the same period in the prior year, the firm posted $1.14 EPS. The business’s revenue was up 24.6% compared to the same quarter last year. On average, analysts expect that Stericycle will post $4.67 earnings per share for the current year.
In other Stericycle news, Director Rodney F. Dammeyer sold 10,188 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the completion of the sale, the director now owns 10,188 shares in the company, valued at approximately $871,074. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the sale, the executive vice president now owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by company insiders.
Several hedge funds have recently made changes to their positions in the company. Credit Agricole S A increased its stake in shares of Stericycle by 165.4% in the first quarter. Credit Agricole S A now owns 129,656 shares of the company’s stock worth $16,361,000 after buying an additional 80,803 shares in the last quarter. Aviva PLC increased its stake in shares of Stericycle by 34.3% in the first quarter. Aviva PLC now owns 118,360 shares of the company’s stock worth $14,936,000 after buying an additional 30,233 shares in the last quarter. Giverny Capital Inc. increased its stake in shares of Stericycle by 29.4% in the first quarter. Giverny Capital Inc. now owns 100,574 shares of the company’s stock worth $12,691,000 after buying an additional 22,861 shares in the last quarter. M&T Bank Corp increased its stake in shares of Stericycle by 13.1% in the first quarter. M&T Bank Corp now owns 14,701 shares of the company’s stock worth $1,854,000 after buying an additional 1,700 shares in the last quarter. Finally, Balentine LLC increased its stake in shares of Stericycle by 34.9% in the first quarter. Balentine LLC now owns 1,064 shares of the company’s stock worth $134,000 after buying an additional 275 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.